Cross-omics strategies and personalised options for lung cancer immunotherapy.
Yan Y, Shen S, Li J, Su L, Wang B, Zhang J, Lu J, Luo H, Han P, Xu K, Shen X, Huang S.
Yan Y, et al. Among authors: xu k.
Front Immunol. 2024 Sep 25;15:1471409. doi: 10.3389/fimmu.2024.1471409. eCollection 2024.
Front Immunol. 2024.
PMID: 39391313
Free PMC article.
Review.